Uncover Early Signals of Drug Risks and Prevent Patient Harm

Ingest and Process Data From the FDA Database

To better discover patterns and detect potential safety signals in adverse drug reactions, quickly upload, process, clean, and filter standard data files from the FDA Adverse Event Reporting System (FAERS) public database with an easy-to-use application.

Detect Drug Risks Early and Prevent Patient Harm

Easily process complex raw data and filter on demographic, drug, reaction, and report characteristics. Get analysis-ready signal surveillance and immediate insights in a reproducible, automated data flow.

Improve Statistical Inference and Signal Detection

Calculate common disproportionality metrics including relative odds ratios (ROR), proportional reporting ratio (PRR), and empirical bayes geometric mean (EBGM) to understand and triage potential drug safety signals found in spontaneously reported systems.

Monitor and Triage Potential Safety Signals

Identify and visualize patterns in your safety data with the solution’s descriptive analytics and charts. Get a complete picture of complex patterns and potential safety concerns through interactive visualization. Visual dashboards help ensure benefit in diverse populations over longer time periods.

Ensure Patient Safety and Increase Regulatory Compliance

Filter reports, generate cohort signals, and run drug/reaction analysis to detect dangerous interactions or drug misuse and discover potential off-label treatment for new indications. Leverage built-in dashboards to discover disparate trends in adverse drug reactions (ADR) across age groups and gender cohorts, and quickly build more custom analysis

Turn Insights Into Alerts

Gather signals from spontaneous reporting systems, set analytics-based alerts and easily push the resulting elements into case management systems for investigation.

Answer Key Pharmacovigilance Questions

The Dataiku Solution for Pharmacovigilance helps answer a broad range of questions like:

• Are there certain at-risk subpopulations of serious adverse drug reactions that clinical research didn’t reveal?
• Are there novel safety signals tied to recently launched drugs that may require a label change or hinder launching in new markets?
• How can I quickly automate data cleaning and processing to triage and address potential safety signals as early as possible?

Go From Advanced Insights to Intelligent Processes Automation

With Dataiku, enhancing safety surveillance practices is just a starting point: quickly move from one use-case to another, leveraging reusable datasets and components across use-cases, and support the rethinking of full business practices.